scholarly journals Rationale for the use of angiotensin ii receptor blockers in patients with left ventricular dysfunction (part I of II)

2005 ◽  
Vol 28 (5) ◽  
pp. 215-218
Author(s):  
T. Barry Levine ◽  
Arlene B. Levine
Keyword(s):  
Angiotensin Ii ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Left Ventricular ◽  
Angiotensin Ii Receptor Blockers ◽  
Angiotensin Ii Receptor ◽  
Receptor Blockers

scholarly journals Angiotensin II receptors blockers in the treatment of patients with cardiorenal syndrome

2015 ◽  
Vol 96 (6) ◽  
pp. 1010-1014
Author(s):  
A A Nasybullina ◽  
O V Bulashova ◽  
E V Khazova ◽  
V M Gazizyanova ◽  
M I Malkova
Keyword(s):  
Heart Failure ◽  
Angiotensin Ii ◽  
Left Ventricular ◽  
Kidney Damage ◽  
Angiotensin Ii Receptor Blockers ◽  
Left Ventricular Ejection ◽  
Angiotensin Ii Receptors ◽  
Angiotensin Ii Receptor ◽  
Cardiac Pathology ◽  
Receptor Blockers

Literature review on the use of angiotensin II receptors blockers in patients with combined pathology of the cardiovascular and renal systems: chronic heart failure and chronic kidney disease is presented. The angiotensin II receptors blockers positive effect is determined by the selective and complete type 1 receptors blockade and simultaneous stimulation of the type 2 receptors. On the one hand angiotensin II blockers are well-studied and widely used class of drugs in patients with cardiac pathology. On the other hand, the efficacy and safety of this drugs group in patients with renal impairment due to cardiac pathology or coexisting urinary system diseases are not well studied. Clinical studies have confirmed the angiotensin II receptor blockers pharmacotherapeutic activity and safety in reducing the cardiovascular events rate, including cardiovascular mortality, myocardial infarction, stroke, number of hospitalizations due to decompensated heart failure. There is data regarding the heart failure poor prognosis in decreased kidney function, but most of these studies were conducted in patients with end-stage renal failure. Data on angiotensin II receptor blockers effect on the course and prognosis of patients with heart failure in association with kidney damage is not enough. The effect of angiotensin II on the heart failure clinical presentation and outcomes according to the left ventricular ejection fraction preservation or reduction, and on the severity of kidney damage is not studied.

Sign in / Sign up

Export Citation Format

Share Document